Tus-Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 398.53 million compared to CNY 346.53 million a year ago. Revenue was CNY 404.65 million compared to CNY 350.53 million a year ago.

Net income was CNY 25.25 million compared to CNY 18.11 million a year ago. Basic earnings per share from continuing operations was CNY 0.1054 compared to CNY 0.0756 a year ago. Diluted earnings per share from continuing operations was CNY 0.1054 compared to CNY 0.0756 a year ago.